The role of the Femoflor-16 study in the diagnosis of vaginal infections during pregnancy
About the Authors
A. N. PrikhodkoBelarus
Gomel
T. N. Zakharenkova
Belarus
Gomel
References
1. Kroon S.J., Ravel J., Huston W.M. Cervicovaginal microbiota, women’s health, and reproductive outcomes // Fertil. Steril. 2018. Vol. 110. Р. 327–336.
2. Aldunate M., Srbinovski D., Hearps A.C., Latham C.F., Ramsland P.A., Gugasyan R., Cone R.A., Tachedjian G., van de Wijgert J.H.H.M., Jespers V. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis // Front. Physiol. 2015. Vol. 6. Р. 164. doi: 10.3389/fphys.2015.00164.
3. Van de Wijgert J.H.H.M., Jespers V. The global health impact of vaginal dysbiosis // Res. Microbiol. 2017. Vol. 168. Р. 859–864. doi: 10.1016/j.resmic.2017.02.003.
4. Muzny C.A., Schwebke J.R. Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses // J. Infect. Dis. 2016.
Review
For citations:
Prikhodko A.N., Zakharenkova T.N. The role of the Femoflor-16 study in the diagnosis of vaginal infections during pregnancy. HIV Infection and Immunosuppressive Disorders. 2023;15(1):86-87. (In Russ.)